Annual Revenue:
$28.83M-$9.19M(-24.17%)Summary
- As of today, ABCL annual revenue is $28.83 million, with the most recent change of -$9.19 million (-24.17%) on December 31, 2024.
- During the last 3 years, ABCL annual revenue has fallen by -$346.37 million (-92.32%).
- ABCL annual revenue is now -94.06% below its all-time high of $485.42 million, reached on December 31, 2022.
Performance
ABCL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$8.96M-$8.13M(-47.58%)Summary
- As of today, ABCL quarterly revenue is $8.96 million, with the most recent change of -$8.13 million (-47.58%) on September 30, 2025.
- Over the past year, ABCL quarterly revenue has increased by +$2.45 million (+37.62%).
- ABCL quarterly revenue is now -97.17% below its all-time high of $316.58 million, reached on March 31, 2022.
Performance
ABCL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$35.32M+$2.45M(+7.45%)Summary
- As of today, ABCL TTM revenue is $35.32 million, with the most recent change of +$2.45 million (+7.45%) on September 30, 2025.
- Over the past year, ABCL TTM revenue has increased by +$2.36 million (+7.16%).
- ABCL TTM revenue is now -94.14% below its all-time high of $603.21 million, reached on September 30, 2022.
Performance
ABCL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABCL Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -24.2% | +37.6% | +7.2% |
| 3Y3 Years | -92.3% | -91.2% | -94.1% |
| 5Y5 Years | +148.3% | -4.3% | +6.7% |
ABCL Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -94.1% | at low | -91.2% | +111.5% | -94.1% | +52.8% |
| 5Y | 5-Year | -94.1% | +148.3% | -97.2% | +111.5% | -94.1% | +52.8% |
| All-Time | All-Time | -94.1% | +226.5% | -97.2% | +179.6% | -94.1% | +1002.9% |
ABCL Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $8.96M(-47.6%) | $35.32M(+7.4%) |
| Jun 2025 | - | $17.08M(+303.4%) | $32.88M(+42.2%) |
| Mar 2025 | - | $4.24M(-16.1%) | $23.11M(-19.8%) |
| Dec 2024 | $28.83M(-24.2%) | $5.05M(-22.4%) | $28.83M(-12.5%) |
| Sep 2024 | - | $6.51M(-11.1%) | $32.96M(-0.3%) |
| Jun 2024 | - | $7.32M(-26.4%) | $33.05M(-7.6%) |
| Mar 2024 | - | $9.95M(+8.4%) | $35.79M(-5.9%) |
| Dec 2023 | $38.02M(-92.2%) | $9.18M(+39.1%) | $38.03M(-24.5%) |
| Sep 2023 | - | $6.60M(-34.4%) | $50.39M(-65.3%) |
| Jun 2023 | - | $10.06M(-17.5%) | $145.18M(-19.8%) |
| Mar 2023 | - | $12.19M(-43.4%) | $181.04M(-62.7%) |
| Dec 2022 | $485.42M | $21.55M(-78.7%) | $485.43M(-19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $101.38M(+120.8%) | $603.21M(+18.9%) |
| Jun 2022 | - | $45.92M(-85.5%) | $507.34M(+3.7%) |
| Mar 2022 | - | $316.58M(+127.2%) | $489.06M(+30.3%) |
| Dec 2021 | $375.20M(+60.9%) | $139.33M(+2429.6%) | $375.22M(-15.5%) |
| Sep 2021 | - | $5.51M(-80.1%) | $443.80M(-0.9%) |
| Jun 2021 | - | $27.64M(-86.4%) | $447.65M(+2.7%) |
| Mar 2021 | - | $202.74M(-2.5%) | $435.90M(+83.3%) |
| Dec 2020 | $233.16M(+1908.0%) | $207.91M(+2120.9%) | $237.81M(+618.3%) |
| Sep 2020 | - | $9.36M(-41.1%) | $33.11M(+39.4%) |
| Jun 2020 | - | $15.89M(+241.1%) | $23.75M(+202.1%) |
| Mar 2020 | - | $4.66M(+45.4%) | $7.86M(+145.4%) |
| Dec 2019 | $11.61M(+31.5%) | $3.20M | $3.20M |
| Dec 2018 | $8.83M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual revenue?
- What is the all-time high annual revenue for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual revenue year-on-year change?
- What is AbCellera Biologics Inc. quarterly revenue?
- What is the all-time high quarterly revenue for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly revenue year-on-year change?
- What is AbCellera Biologics Inc. TTM revenue?
- What is the all-time high TTM revenue for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM revenue year-on-year change?
What is AbCellera Biologics Inc. annual revenue?
The current annual revenue of ABCL is $28.83M
What is the all-time high annual revenue for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual revenue is $485.42M
What is AbCellera Biologics Inc. annual revenue year-on-year change?
Over the past year, ABCL annual revenue has changed by -$9.19M (-24.17%)
What is AbCellera Biologics Inc. quarterly revenue?
The current quarterly revenue of ABCL is $8.96M
What is the all-time high quarterly revenue for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly revenue is $316.58M
What is AbCellera Biologics Inc. quarterly revenue year-on-year change?
Over the past year, ABCL quarterly revenue has changed by +$2.45M (+37.62%)
What is AbCellera Biologics Inc. TTM revenue?
The current TTM revenue of ABCL is $35.32M
What is the all-time high TTM revenue for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM revenue is $603.21M
What is AbCellera Biologics Inc. TTM revenue year-on-year change?
Over the past year, ABCL TTM revenue has changed by +$2.36M (+7.16%)